幹細胞治療市場：按細胞來源、應用、最終用戶和地區分類

2025 年全球幹細胞治療市場規模預估為 186.1 億美元，預計到 2032 年將達到 783.9 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 22.8%。

數字。 2025 年幹細胞治療市場佔有率（按地區分類）

幹細胞治療是再生醫學中一個很有前景的新領域，利用幹細胞及其衍生物來修復和再生受損的組織和細胞。從生命的早期階段開始，所有人類體內都存在幹細胞。幹細胞具有透過細胞分裂自我更新並分化為多種特殊細胞類型的獨特能力。這些細胞透過移植和組織再生，在治療許多無法治癒的疾病方面具有巨大的潛力。幹細胞研究旨在利用幹細胞的自然力量來開發可治療多種疾病的治療方法，包括癌症、糖尿病、心臟病、骨關節炎和神經系統疾病。

市場動態：

全球幹細胞治療市場的成長受到慢性病增加、幹細胞治療成功率提高、再生醫學的快速進步、幹細胞治療研發投入增加以及新治療方法的核准等因素的推動。然而，幹細胞研究、開發和治療應用的高成本以及與胚胎幹細胞相關的倫理問題可能會阻礙市場的成長。新的幹細胞來源的開發、高效生產幹細胞的先進技術平台的開發、以及應用人工智慧更快地開發客製化的幹細胞療法，都有可能為未來的市場成長提供機會。在全球範圍內開發負擔得起的幹細​​胞療法和有效的幹細胞儲存技術將有助於解決尚未滿足的需求並擴大市場。

本研究的主要特點

• 本報告對全球幹細胞治療市場進行了詳細分析，並展示了預測期（2025-2032 年）的市場規模（以十億美元計）和年複合成長率（CAGR%），以 2024 年為基準年。
• 它還強調了各個領域的潛在收益成長機會，並說明了該市場的引人注目的投資提案矩陣。
• 它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
• 本報告根據公司亮點、產品系列、關鍵亮點、績效和策略等參數，概述了全球幹細胞治療市場的主要企業。
• 主要企業：Osiris Therapeutics, Inc.、Kolon TissueGene, Inc.、JCR Pharmaceuticals Co. Ltd.、Pharmacell Co., Inc.、Stemedica Cell Technologies, Inc.、Magellan、Medipost Co. Ltd.、Athersys Inc.、Biorestorative Therapies Inc.、Brainstorm Limited. LTD.、NuVasive Inc.、RTI Surgical、AlloSource
• 報告中的見解將使負責人和企業經營團隊能夠就未來產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
• 全球幹細胞治療市場迎合了該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
• 相關人員將透過用於分析全球幹細胞治療市場的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規與趨勢分析

• 市場動態
  • 驅動程式
  • 限制因素
  • 機會
• 影響分析
• 市場趨勢
• 主要進展
• 監管情景
• 收購和合作場景
• 資金籌措和投資
• PEST分析
• 波特的分析

4. 全球幹細胞治療市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 市場影響

5. 全球幹細胞治療市場，依細胞來源，2020-2032 年（十億美元）

• 成體幹細胞
• 誘導多功能細胞
• 胚胎幹細胞
• 其他

6. 全球幹細胞治療市場，按應用分類，2020-2032 年（十億美元）

• 肌肉骨骼疾病
• 傷口和損傷
• 癌症
• 自體免疫疾病
• 其他

7. 2020 年至 2032 年全球幹細胞治療市場（按最終用戶分類）（十億美元）

• 醫院
• 細胞銀行
• 學術研究所

8. 2020 年至 2032 年全球幹細胞治療市場（按地區分類）（十億美元）

• 北美洲
• 拉丁美洲
• 歐洲
• 亞太地區
• 中東
• 非洲

第9章 競爭格局

• 公司簡介
  • Osiris Therapeutics, Inc.
  • Kolon TissueGene, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Anterogen Co. Ltd.
  • Pharmicell Co., Inc.
  • Stemedica Cell Technologies, Inc.
  • Magellan
  • Medipost Co., Ltd
  • Athersys Inc.
  • Biorestorative Therapies Inc.
  • Brainstorm Cell Limited.
  • ViaCyte Inc.
  • Cellular Biomedicine Group
  • ANTEROGEN. CO, LTD.
  • NuVasive Inc.
  • RTI Surgical
  • AlloSource

第 10 章分析師建議

• 機會
• 分析師觀點
• Coherent Opportunity Map

第 11 章 參考文獻與調查方法

• 參考
• 調查方法

Global Stem Cell Therapy Market is estimated to be valued at USD 18.61 Bn in 2025 and is expected to reach USD 78.39 Bn by 2032, growing at a compound annual growth rate (CAGR) of 22.8% from 2025 to 2032.

Figure. Stem Cell Therapy Market Share (%), By Region 2025

Stem cell therapy is a promising and emerging field in regenerative medicine that involves the use of stem cells and their derivatives to repair or regenerate damaged tissues and cells. Stem cells are found in all human beings from a very early stage of life. These have the unique ability to renew themselves through cell division and differentiate into a diverse range of specialized cell types. These cells hold great potential to treat many incurable diseases through transplantation or tissue regeneration. Stem cell research aims to harness the natural powers of stem cells to develop therapies that can cure various diseases like cancer, diabetes, heart disease, osteoarthritis and neurological disorders.

Market Dynamics:

Global stem cell therapy market growth is driven by factors such as rising prevalence of chronic diseases, increasing success rates of stem cell therapies, rapid advancements in regenerative medicine, growing investments for research and development in stem cell therapies and approval of new therapies. However, high costs involved in stem cell research & development and therapeutic applications along with ethical issues related to embryonic stem cells can hamper the market growth. Emergence of new stem cell sources, development of advanced technology platforms for efficient production of stem cells, and application of artificial intelligence for faster development of customized stem cell therapies can offer opportunities for the market growth in the future. Providing affordable stem cell therapies globally and developing efficient techniques for stem cell banking can help to address unmet needs and expand the market reach.

Key Features of the Study:

• This report provides an in-depth analysis of the global stem cell therapy market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global stem cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., Stemedica Cell Technologies, Inc., Magellan, Medipost Co., Ltd, Athersys Inc., Biorestorative Therapies Inc., Brainstorm Cell Limited., ViaCyte Inc., Cellular Biomedicine Group, ANTEROGEN. C.O., LTD., NuVasive Inc., RTI Surgical, AlloSource.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global stem cell therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell therapy market.

Detailed Segmentation-

• By Cell Source:
  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Embryonic Stem Cells
  • Others
• By Application:
  • Musculoskeletal Disorders
  • Wounds and Injuries
  • Cancer
  • Autoimmune Disorders
  • Others
• By End User:
  • Hospitals
  • Cell Banks
  • Academic and Research Institutes
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Osiris Therapeutics, Inc.
  • Kolon TissueGene, Inc.
  • JCR Pharmaceuticals Co., Ltd.
  • Anterogen Co. Ltd.
  • Pharmicell Co., Inc.
  • Stemedica Cell Technologies, Inc.
  • Magellan
  • Medipost Co., Ltd
  • Athersys Inc.
  • Biorestorative Therapies Inc.
  • Brainstorm Cell Limited.
  • ViaCyte Inc.
  • Cellular Biomedicine Group
  • C.O., LTD.
  • NuVasive Inc.
  • RTI Surgical
  • AlloSource

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Cell Source
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Stem Cell Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Stem Cell Therapy Market, By Cell Source, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Adult Stem Cells
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Induced Pluripotent Stem Cells
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Embryonic Stem Cells
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Stem Cell Therapy Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Musculoskeletal Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Wounds and Injuries
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Autoimmune Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Stem Cell Therapy Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cell Banks
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutes
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Stem Cell Therapy Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Cell Source, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Osiris Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Kolon TissueGene, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • JCR Pharmaceuticals Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Anterogen Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pharmicell Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Stemedica Cell Technologies, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Magellan
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medipost Co., Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Athersys Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Biorestorative Therapies Inc.
  • Brainstorm Cell Limited.
  • ViaCyte Inc.
  • Cellular Biomedicine Group
  • ANTEROGEN. C.O., LTD.
  • NuVasive Inc.
  • RTI Surgical
  • AlloSource

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact